Retinoic acid represses invasion and stem cell phenotype by induction of the metastasis suppressors RARRES1 and LXN

Oncogenesis

Volumn 2, Issue , 2013, Pages

  Oldridge, E E ^a   Walker, H F ^a   Stower, M J ^b   Simms, M S ^c,d   Mann, V M ^c,d   Collins, A T ^a   Pellacani, D ^a   Maitland, N J ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

^b YORK HOSPITAL   (United Kingdom)

^c CASTLE HILL HOSPITAL   (United Kingdom)

^d UNIVERSITY OF HULL   (United Kingdom)

Author keywords

differentiation; LXN; prostate; RARRES1; retinoic acid; stem cell

Indexed keywords

LATEXIN; RETINOIC ACID; RETINOIC ACID RECEPTOR RESPONDER 1; SMALL INTERFERING RNA; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL INVASION; CELL SUBPOPULATION; COLONY FORMING UNIT; DNA METHYLATION; DOWN REGULATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; INTRACELLULAR SPACE; MALE; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

EID: 84880544280     PISSN: None     EISSN: 21579024     Source Type: Journal    
DOI: 10.1038/oncsis.2013.6     Document Type: Article

References (67)

1. Nagpal S, Patel S, Asano AT, Johnson AT, Duvic M, Chandraratna RA. Tazaroteneinduced gene 1 (TIG1), a novel retinoic acid receptor-responsive gene in skin. J Invest Dermatol 1996; 106: 269-274. (Pubitemid 26096423)
2. Hatanaka Y, Uratani Y, Takiguchi-Hayashi K, Omori A, Sato K, Miyamoto M et al. Intracortical regionality represented by specific transcription for a novel protein, latexin. Eur J Neurosci 1994; 6: 973-982. (Pubitemid 24185321)
3. Arimatsu Y. Latexin: a molecular marker for regional specification in the neocortex. Neurosci Res 1994; 20: 131-135. (Pubitemid 24273618)
4. Jing C, El-Ghany MA, Beesley C, Foster CS, Rudland PS, Smith P et al. Tazaroteneinduced gene 1 (TIG1) expression in prostate carcinomas and its relationship to tumorigenicity. J Natl Cancer Inst 2002; 94: 482-490. (Pubitemid 34411286)
5. Kwok WK, Pang JC, Lo KW, Ng HK. Role of the RARRES1 gene in nasopharyngeal carcinoma. Cancer Genet Cytogenet 2009; 194: 58-64.
6. Peng Z, Shen R, Li YW, Teng KY, Shapiro CL, Lin HJ. Epigenetic repression of RARRES1 is mediated by methylation of a proximal promoter and a loss of CTCF binding. PLoS One 2012; 7: e36891.
7. Wu CC, Shyu RY, Chou JM, Jao SW, Chao PC, Kang JC et al. RARRES1 expression is significantly related to tumour differentiation and staging in colorectal adenocarcinoma. Eur J Cancer 2006; 42: 557-565.
8. Ohnishi S, Okabe K, Obata H, Otani K, Ishikane S, Ogino H et al. Involvement of tazarotene-induced gene 1 in proliferation and differentiation of human adipose tissue-derived mesenchymal stem cells. Cell Prolif 2009; 42: 309-316.
9. Takai N, Kawamata N, Walsh CS, Gery S, Desmond JC, Whittaker S et al. Discovery of epigenetically masked tumor suppressor genes in endometrial cancer. Mol Cancer Res 2005; 3: 261-269. (Pubitemid 40656813)
10. Liang Y, Jansen M, Aronow B, Geiger H, Van Zant G. The quantitative trait gene latexin influences the size of the hematopoietic stem cell population in mice. Nat Genet 2007; 39: 178-188. (Pubitemid 46184348)
11. Mitsunaga K, Kikuchi J, Wada T, Furukawa Y. Latexin regulates the abundance of multiple cellular proteins in hematopoietic stem cells. J Cell Physiol 2011; 227: 1138-1147.
12. Li Y, Basang Z, Ding H, Lu Z, Ning T, Wei H et al. Latexin expression is downregulated in human gastric carcinomas and exhibits tumor suppressor potential. BMC Cancer 2011; 11: 121.
13. Normant E, Martres MP, Schwartz JC, Gros C. Purification, cDNA cloning, functional expression, and characterization of a 26-kDa endogenous mammalian carboxypeptidase inhibitor. Proc Natl Acad Sci USA 1995; 92: 12225-12229. (Pubitemid 26014043)
14. Pallares I, Bonet R, Garcia-Castellanos R, Ventura S, Aviles FX, Vendrell J et al. Structure of human carboxypeptidase A4 with its endogenous protein inhibitor, latexin. Proc Natl Acad Sci USA 2005; 102: 3978-3983. (Pubitemid 40388541)
15. Aagaard A, Listwan P, Cowieson N, Huber T, Ravasi T, Wells CA et al. An inflammatory role for the mammalian carboxypeptidase inhibitor latexin: relationship to cystatins and the tumor suppressor TIG1. Structure 2005; 13: 309-317. (Pubitemid 40247706)
16. Wood RJ, Tchack L, Angelo G, Pratt RE, Sonna LA. DNA microarray analysis of vitamin D-induced gene expression in a human colon carcinoma cell line. Physiol Genomics 2004; 17: 122-129. (Pubitemid 38924158)
17. Youssef EM, Chen XQ, Higuchi E, Kondo Y, Garcia-Manero G, Lotan R et al. Hypermethylation and silencing of the putative tumor suppressor Tazaroteneinduced gene 1 in human cancers. Cancer Res 2004; 64: 2411-2417. (Pubitemid 38523894)
18. Zhang J, Liu L, Pfeifer GP. Methylation of the retinoid response gene TIG1 in prostate cancer correlates with methylation of the retinoic acid receptor beta gene. Oncogene 2004; 23: 2241-2249. (Pubitemid 38482540)
19. Mizuiri H, Yoshida K, Toge T, Oue N, Aung PP, Noguchi T et al. DNA methylation of genes linked to retinoid signaling in squamous cell carcinoma of the esophagus: DNA methylation of CRBP1 and TIG1 is associated with tumor stage. Cancer Sci 2005; 96: 571-577. (Pubitemid 41488420)
20. Kwong J, Lo KW, Chow LS, Chan FL, To KF, Huang DP. Silencing of the retinoid response gene TIG1 by promoter hypermethylation in nasopharyngeal carcinoma. Int J Cancer 2005; 113: 386-392. (Pubitemid 40038705)
21. Yanatatsaneejit P, Chalermchai T, Kerekhanjanarong V, Shotelersuk K, Supiyaphun P, Mutirangura A et al. Promoter hypermethylation of CCNA1, RARRES1, and HRASLS3 in nasopharyngeal carcinoma. Oral Oncol 2008; 44: 400-406. (Pubitemid 351391854)
22. Ellinger J, Bastian PJ, Jurgan T, Biermann K, Kahl P, Heukamp LC et al. CpG island hypermethylation at multiple gene sites in diagnosis and prognosis of prostate cancer. Urology 2008; 71: 161-167. (Pubitemid 351173282)
23. Tamura G, So K, Miyoshi H, Honda T, Nishizuka S, Motoyama T. Quantitative assessment of gene methylation in neoplastic and non-neoplastic gastric epithelia using methylation-specific DNA microarray. Pathol Int 2009; 59: 895-899.
24. Son MS, Kang MJ, Park HC, Chi SG, Kim YH. Expression and mutation analysis of TIG1 (tazarotene-induced gene 1) in human gastric cancer. Oncol Res 2009; 17: 571-580.
25. Anderton JA, Lindsey JC, Lusher ME, Gilbertson RJ, Bailey S, Ellison DW et al. Global analysis of the medulloblastoma epigenome identifies disease-subgroupspecific inactivation of COL1A2. Neuro Oncol 2008; 10: 981-994.
26. Muthusamy V, Duraisamy S, Bradbury CM, Hobbs C, Curley DP, Nelson B et al. Epigenetic silencing of novel tumor suppressors in malignant melanoma. Cancer Res 2006; 66: 11187-11193. (Pubitemid 46009946)
27. Kloth M, Goering W, Ribarska T, Arsov C, Sorensen KD, Schulz WA. The SNP rs6441224 influences transcriptional activity and prognostically relevant hypermethylation of RARRES1 in prostate cancer. Int J Cancer 2012; 131: E897-E904.
28. Sahab ZJ, Hall MD, Me Sung Y, Dakshanamurthy S, Ji Y, Kumar D et al. Tumor suppressor RARRES1 interacts with cytoplasmic carboxypeptidase AGBL2 to regulate the alpha-tubulin tyrosination cycle. Cancer Res 2011; 71: 1219-1228.
29. Uratani Y, Takiguchi-Hayashi K, Miyasaka N, Sato M, Jin M, Arimatsu Y. Latexin, a carboxypeptidase A inhibitor, is expressed in rat peritoneal mast cells and is associated with granular structures distinct from secretory granules and lysosomes. Biochem J. 2000; 346(Pt 3): 817-826. (Pubitemid 30171046)
30. Birnie R, Bryce SD, Roome C, Dussupt V, Droop A, Lang SH et al. Gene expression profiling of human prostate cancer stem cells reveals a pro-inflammatory phenotype and the importance of extracellular matrix interactions. Genome Biol 2008; 9: R83.
31. Bastien J, Rochette-Egly C. Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene 2004; 328: 1-16. (Pubitemid 38352876)
32. Sammons J, Ahmed N, Khokher MA, Hassan HT. Mechanisms mediating the inhibitory effect of all-trans retinoic acid on primitive hematopoietic stem cells in human long-term bone marrow culture. Stem Cells 2000; 18: 214-219. (Pubitemid 30341670)
33. Luo P, Wang A, Payne KJ, Peng H, Wang JG, Parrish YK et al. Intrinsic retinoic acid receptor alpha-cyclin-dependent kinase-activating kinase signaling involves coordination of the restricted proliferation and granulocytic differentiation of human hematopoietic stem cells. Stem Cells 2007; 25: 2628-2637. (Pubitemid 47582756)
34. Simandi Z, Balint BL, Poliska S, Ruhl R, Nagy L. Activation of retinoic acid receptor signaling coordinates lineage commitment of spontaneously differentiating mouse embryonic stem cells in embryoid bodies. FEBS Lett 2010; 584: 3123-3130.
35. Su ZY, Li Y, Zhao XL, Zhang M. All-trans retinoic acid promotes smooth muscle cell differentiation of rabbit bone marrow-derived mesenchymal stem cells. J Zhejiang Univ Sci B. 2010; 11: 489-496.
36. Ginestier C, Wicinski J, Cervera N, Monville F, Finetti P, Bertucci F et al. Retinoid signaling regulates breast cancer stem cell differentiation. Cell Cycle 2009; 8: 3297-3302.
37. Chute JP, Muramoto GG, Whitesides J, Colvin M, Safi R, Chao NJ et al. Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells. Proc Natl Acad Sci USA 2006; 103: 11707-11712. (Pubitemid 44182515)
38. van den Hoogen C, van der Horst G, Cheung H, Buijs JT, Lippitt JM, Guzman-Ramirez N et al. High aldehyde dehydrogenase activity identifies tumor-initiating and metastasis-initiating cells in human prostate cancer. Cancer Res 2010; 70: 5163-5173.
39. Peehl DM, Wong ST, Stamey TA. Vitamin A regulates proliferation and differentiation of human prostatic epithelial cells. Prostate 1993; 23: 69-78. (Pubitemid 23250086)
40. Seo R, McGuire M, Chung M, Bushman W. Inhibition of prostate ductal morphogenesis by retinoic acid. J Urol 1997; 158(3 Pt 1): 931-935.
41. Lohnes D, Mark M, Mendelsohn C, Dolle P, Decimo D, LeMeur M et al. Developmental roles of the retinoic acid receptors. J Steroid Biochem Mol Biol 1995; 53: 475-486.
42. Huang J, Powell WC, Khodavirdi AC, Wu J, Makita T, Cardiff RD et al. Prostatic intraepithelial neoplasia in mice with conditional disruption of the retinoid X receptor alpha allele in the prostate epithelium. Cancer Res 2002; 62: 4812-4819.
43. Vezina CM, Allgeier SH, Fritz WA, Moore RW, Strerath M, Bushman W et al. Retinoic acid induces prostatic bud formation. Dev Dyn 2008; 237: 1321-1333. (Pubitemid 351668816)
44. Aboseif SR, Dahiya R, Narayan P, Cunha GR. Effect of retinoic acid on prostatic development. Prostate 1997; 31: 161-167. (Pubitemid 27225199)
45. Rivera-Gonzalez GC, Droop AP, Rippon HJ, Tiemann K, Pellacani D, Georgopoulos LJ et al. Retinoic acid and androgen receptors combine to achieve tissue specific control of human prostatic transglutaminase expression: a novel regulatory network with broader significance. Nucleic Acids Res 2012; 40: 4825-4840.
46. Vaissiere T, Sawan C, Herceg Z. Epigenetic interplay between histone modifications and DNA methylation in gene silencing. Mutat Res 2008; 659: 40-48.
47. Tokumaru Y, Harden SV, Sun DI, Yamashita K, Epstein JI, Sidransky D. Optimal use of a panel of methylation markers with GSTP1 hypermethylation in the diagnosis of prostate adenocarcinoma. Clin Cancer Res 2004; 10: 5518-5522. (Pubitemid 39100490)
48. Grisanzio C, Signoretti S. p63 in prostate biology and pathology. J Cell Biochem 2008; 103: 1354-1368. (Pubitemid 351490706)
49. Gal-Yam EN, Egger G, Iniguez L, Holster H, Einarsson S, Zhang X et al. Frequent switching of Polycomb repressive marks and DNA hypermethylation in the PC3 prostate cancer cell line. Proc Natl Acad Sci USA 2008; 105: 12979-12984.
50. Ohm JE, McGarvey KM, Yu X, Cheng L, Schuebel KE, Cope L et al. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet 2007; 39: 237-242. (Pubitemid 46184356)
51. Schlesinger Y, Straussman R, Keshet I, Farkash S, Hecht M, Zimmerman J et al. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat Genet 2007; 39: 232-236. (Pubitemid 46184355)
52. Widschwendter M, Fiegl H, Egle D, Mueller-Holzner E, Spizzo G, Marth C et al. Epigenetic stem cell signature in cancer. Nat Genet 2007; 39: 157-158. (Pubitemid 46184343)
53. Nwankwo JO. Anti-metastatic activities of all-trans retinoic acid, indole-3-carbinol and (\+)-catechin in Dunning rat invasive prostate adenocarcinoma cells. Anticancer Res 2002; 22: 4129-4135. (Pubitemid 36134444)
54. Dahiya R, Park HD, Cusick J, Vessella RL, Fournier G, Narayan P. Inhibition of tumorigenic potential and prostate-specific antigen expression in LNCaP human prostate cancer cell line by 13-cis-retinoic acid. Int J Cancer 1994; 59: 126-132. (Pubitemid 24310958)
55. Webber MM, Waghray A. Urokinase-mediated extracellular matrix degradation by human prostatic carcinoma cells and its inhibition by retinoic acid. Clin Cancer Res 1995; 1: 755-761.
56. Lan L, Cui D, Luo Y, Shi BY, Deng LL, Zhang GY et al. Inhibitory effects of retinoic acid on invasiveness of human thyroid carcinoma cell lines in vitro. J Endocrinol Invest 2009; 32: 731-738.
57. Lotan R. Retinoids as modulators of tumor cells invasion and metastasis. Semin Cancer Biol 1991; 2: 197-208.
58. Messi E, Florian MC, Caccia C, Zanisi M, Maggi R. Retinoic acid reduces human neuroblastoma cell migration and invasiveness: effects on DCX, LIS1, neurofilaments-68 and vimentin expression. BMC Cancer 2008; 8: 30.
59. Nakajima M, Lotan D, Baig MM, Carralero RM, Wood WR, Hendrix MJ et al. Inhibition by retinoic acid of type IV collagenolysis and invasion through reconstituted basement membrane by metastatic rat mammary adenocarcinoma cells. Cancer Res 1989; 49: 1698-1706. (Pubitemid 19108390)
60. Sheridan C, Kishimoto H, Fuchs RK, Mehrotra S, Bhat-Nakshatri P, Turner CH et al. CD44\+/CD24-breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Res 2006; 8: R59.
61. Chen HL, Seol H, Brown KJ, Gordish-Dressman H, Hill A, Gallo V et al. Secretome Survey of Human Plexiform Neurofibroma Derived Schwann Cells Reveals a Secreted form of the RARRES1 Protein. Int J Mol Sci 2012; 13: 9380-9399.
62. Whipple RA, Matrone MA, Cho EH, Balzer EM, Vitolo MI, Yoon JR et al. Epithelial-tomesenchymal transition promotes tubulin detyrosination and microtentacles that enhance endothelial engagement. Cancer Res 2010; 70: 8127-8137.
63. Collins AT, Habib FK, Maitland NJ, Neal DE. Identification and isolation of human prostate epithelial stem cells based on alpha(2)beta(1)-integrin expression. J Cell Sci 2001; 114(Pt 21): 3865-3872. (Pubitemid 33094701)
64. Richardson GD, Robson CN, Lang SH, Neal DE, Maitland NJ, Collins AT. CD133, a novel marker for human prostatic epithelial stem cells. J Cell Sci 2004; 117(Pt 16): 3539-3545. (Pubitemid 39206394)
65. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005; 65: 10946-10951. (Pubitemid 41713363)
66. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008; 3: 1101-1108. (Pubitemid 351818697)
67. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 1987; 47: 3239-3245. (Pubitemid 17082655)